Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Merck
McKesson
Mallinckrodt
Colorcon

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

See Plans and Pricing

« Back to Dashboard

Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

Docket   Start Trial Date Filed 2014-09-03
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Mitchell S. Goldberg
Jury Demand None Referred To
Parties ALEMBIC GLOBAL HOLDING S/A; ALEMBIC GLOBAL HOLDING SA; ALEMBIC PHARMACEUTICALS INC.; ALEMBIC PHARMACEUTICALS LTD.; ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED; AMNEAL PHARMACEUTICALS CO. INDIA PVT. LTD.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; BRECKENRIDGE PHARMACEUTICAL INC.; FOREST LABORATORIES HOLDINGS LTD.; FOREST LABORATORIES LLC; HIKMA PHARMACEUTICALS LLC; HIKMA PHARMACEUTICALS PLC; SIGMAPHARM LABORATORIES LLC; WEST-WARD PHARMACEUTICALS CORP.
Patents 4,371,516; 5,763,476; 7,741,358; 8,022,228
Attorneys Aaron G. Clay; Aaron Gleaton Clay; Aiyda Ghahramani; Alton L. Hare , III; Anthony G. Simon; Anthony R. Friedman; Azy S. Kokabi; Benjamin R. Askew; Beth D. Jacob; Charles E. Lipsey; Christopher T. Griffith; Clifford E. Katz; David A. Bilson; Eve H. Ormerod; Helen H. Ji; Howard W. Levine; Imron T. Aly; Jack B. Blumenfeld; Jeffrey Thomas Castellano; Jennifer M. Rutter; Jeremy A. Tigan; Joel M. Wallace; John C. Phillips , Jr.; John E. Rosenquist; John K. Hsu; John Simon; Jonathan R. Davies; Karen Elizabeth Keller; Karen L. Pascale; Karen Shen; Ksenia Takhistova; Marc R. Wezowski; Maryellen Noreika; Megan C. Haney; Michael K. Levy; Michael P. Kella; Michael R. Dzwonczyk; Michael W. Glynn; Nathan Newbold; Neal C. Belgam; Nitya Anand; Paul M. Richter; Richard D. Kirk; Robert F. Green; Robert Karl Beste , III; Sanya Sukduang; Sara E. Bussiere; Seth R. Ogden; Stephen B. Brauerman; Steven J. Lee Ph.D.; Timothy D. Krieger; Vanessa Ribeiro Tiradentes
Firms Bayard, P.A.; Gould & Ratner LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories LLC v. Sigmapharm Laboratories LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 [PROPOSED] ORDEROF INFRINGEMENT OF U.S. PATENT NO. 5,763,476 BY ALEMBIC filed by Forest Laboratories …3 September 2014 1:14-cv-01119 830 Patent None District Court, D. Delaware External link to document
0000-00-00 1 paragraphs 1-6. 8. United States Patent No. 5,763,476 (“the ’476 patent”), titled “Sublingual or Buccal…United States Patent No. 5,763,476 constitute infringement of one or more claims of said patent under 35 U.S.C…follows: a) declare that United States Patent Nos. 5,763,476 and 7,741,358 are valid; b) declare that…(A), Sigmapharm infringed United States Patent Nos. 5,763,476 and 7,741,358 by submitting ANDA No. 206107…than the expiration date of United States Patent Nos. 5,763,476 and 7,741,358, including any exclusivities External link to document
0000-00-00 102 Infringement of Asserted Claims of U.S. Patent No. 5,763,476 by Amneal by Forest Laboratories Holdings…3 September 2014 1:14-cv-01119 830 Patent None District Court, D. Delaware External link to document
0000-00-00 133 language of U.S. Patent Nos. 5,763,476, (the '476 patent), 7,741,358 (the '358 patent), and 8,022,228…treatments ... disclosed in U.S. Patent No. 4, 145,434 and 5,763,476." (D.I. 58, ex. 5, U.S. App.…claim 1 of the '228 patent which shares a specification with the '358 patent. All references in …8,022,228 (the '228 patent) shall be construed consistent with the tenets of claim construction set… The '476 Patent 1. "Tension, excitation, anxiety External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Colorcon
Moodys
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.